StockData
ImageneBio, Inc. logo

ImageneBio, Inc. (IMA) stock

IMANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 6/30
$3.81−0.09 (-2.31%)

Close on Nov 18, 2026Market cap $43.25MP/E –Yield –

ImageneBio shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

ImageneBio's shares outstanding was 16M at Jun 30, 2026. For fiscal 2025 it was 5M, down 89.9% from the year before. The highest annual figure on record is 48M in fiscal 2024.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 20255M-89.9%
FY2024Dec 31, 202448M+15.6%
FY2023Dec 31, 202342M+15.3%
FY2022Dec 31, 202236M+29.3%
FY2021Dec 31, 202128M+911.9%
FY2020Dec 31, 20203M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 202616M+571.6%
Q1 FY2026Mar 31, 202611M+366.2%
Q4 FY2025Dec 31, 20258M-83.3%
Q3 FY2025Sep 30, 20259M-82.3%
Q2 FY2025Jun 30, 20252M-95.0%
Q1 FY2025Mar 31, 20252M-95.0%
Q4 FY2024Dec 31, 202448M+0.8%
Q3 FY2024Sep 30, 202448M+11.1%
Q2 FY2024Jun 30, 202448M+22.8%
Q1 FY2024Mar 31, 202448M+33.1%
Q4 FY2023Dec 31, 202348M+32.0%
Q3 FY2023Sep 30, 202343M+19.8%
Q2 FY2023Jun 30, 202339M+8.7%
Q1 FY2023Mar 31, 202336M+0.5%
Q4 FY2022Dec 31, 202236M+0.7%
Q3 FY2022Sep 30, 202236M+1.1%
Q2 FY2022Jun 30, 202236M+0.9%
Q1 FY2022Mar 31, 202236M+837.0%
Q4 FY2021Dec 31, 202136M+1066.2%
Q3 FY2021Sep 30, 202136M+1248.8%
Q2 FY2021Jun 30, 202136M+1248.5%
Q1 FY2021Mar 31, 20214M+45.0%
Q4 FY2020Dec 31, 20203M–
Q3 FY2020Sep 30, 20203M–
Q2 FY2020Jun 30, 20203M–
Q1 FY2020Mar 31, 20203M–

More ImageneBio figures

See a number that looks wrong?